GUIDELINES FOR SUPPORT OF SCIENTIFIC MEETINGS BY NIH - ADDITIONAL INFORMATION
FOR NIDA CONFERENCE GRANTS
Release Date: May 1, 2000
NOTICE: DA-00-007
National Institute on Drug Abuse
This Notice provides additional information related to NIDA support of
conference grants, as announced in the NIH Guide of October 30, 1998,
available at
http://grants.nih.gov/grants/guide/notice-files/not98-151.html.
NIDA is interested in supporting investigator initiated scientific
meetings that will advance the mission of the Institute. NIH defines a
scientific meeting as a gathering, symposium, seminar, workshop, or
other organized, formal conference where persons assemble to coordinate,
exchange and disseminate information or to explore or clarify a defined
subject, problem or area of knowledge. NIDA wishes to elaborate on
this definition and clarify the types of scientific meetings for which
it will consider applications under the R13 mechanism. NIDA will support
small meetings in their entirety and will contribute support toward
large conferences that have other support. In both cases, the NIDA
supported portion of the meeting should primarily focus on advancing the
research development mission of the Institute. Meetings should advance
the research agenda by fostering creativity and innovation and not
solely by providing training in specific techniques, methods, or
technologies. Insofar as the agenda, format, and facilities will allow,
meetings should maximize the number of participants and be inclusive of
a large number of participants with varied scientific backgrounds and
demographic characteristics. They should foster interactions and
exchange among persons who would otherwise be unlikely to engage in such
interactions and exchanges. Participation should not be restricted to
persons who already regularly associate or communicate through other
NIDA sponsored events, conferences, associations, or other means. The
inclusion of junior investigators and post-doctoral fellows is
encouraged. In the case of meetings proposed to advance international
collaboration, it should be clear how such collaboration will advance
U.S. interests.
NIDA-supported meetings should result in a specific product or
measurable intermediate outcome that allows evaluation of a meeting’s
effectiveness in fostering the final outcome of advancing NIDA-relevant
research. Such products might include published papers or monographs,
reports or data made available through the Internet, evaluation data on
participation and interactions fostered through the meeting, or
examinations of specific outcomes.
NIDA will support such meetings with up to $25,000 per year. The
Principal Investigator, with co-signature of the applicant
organization’s designated official, must submit a letter of request and
receive advance permission from NIDA in order to submit. Send such
requests to the NIDA contact named below.
Applicants may request funding for multiple years. Because of the
difficulty in planning an agenda, topics, and speakers in subsequent
years, NIDA encourages multiple year applications only when the
applicant organization has a well established history of conducting
meetings and can document the organizational ability to anticipate and
respond to emerging needs, or when the application can provide specific
details on the agenda, topics, and speakers for ensuing years. In the
latter case, the application should also provide a rationale for
anticipating that the needs will not change.
In addition to the standard NIH criteria for conference grants, applications
will be evaluated on the basis of the meeting’s likelihood of advancing a
research agenda and the quality of the plans for providing and evaluating
specific products and outcomes.
INQUIRIES
Inquiries are encouraged. The opportunity to clarify any issues or answer
questions from potential applicants is welcome. In addition, any applicant
requesting more than $25,000 in a single year of support must secure approval
to submit and be considered.
For further information, contact:
Teresa Levitin, Ph.D.
Office of Extramural Affairs
National Institute on Drug Abuse
6001 Executive Boulevard, Room 3158, MSC 9547
Bethesda, MD 20892-9547
Telephone: (301) 443-2755
FAX: (301) 443-0538
Email: tlevitin@nida.nih.gov
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
|
|
|
Department of Health and Human Services (HHS)
|
|
|
|
NIH... Turning Discovery Into Health®
|